Dopamine induces autophagic cell death and α-synuclein increase in human neuroblastoma SH-SY5Y cells

Journal of Neuroscience Research

Volumn 73, Issue 3, 2003, Pages 341-350

  Gómez Santos, Cristina ^a   Ferrer, Isidre ^a   Santidrián, Antonio F ^a   Barrachina, Marta ^a   Gil, Joan ^a   Ambrosio, Santiago ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

synuclein; Autophagy; Dopamine; Human neuroblastoma SH SY5Y; Oxidative stress; Stress activated kinases

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ALPHA SYNUCLEIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ASCORBIC ACID; DOPAMINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NOMIFENSINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CELL ADHESION; CELL INCLUSION; CELL PROTECTION; CELL VACUOLE; CELL VIABILITY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; LEWY BODY; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-SYNUCLEIN; AUTOPHAGY; CELL DEATH; CELL SURVIVAL; DOPAMINE; ENZYME ACTIVATION; HUMANS; LEWY BODIES; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE TISSUE PROTEINS; NEUROBLASTOMA; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SYNUCLEINS; TUMOR CELLS, CULTURED;

EID: 0043173825     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10663     Document Type: Article

References (57)

1. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Márquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. 1997. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12:25-31.
2. Barzilai A, Melamed E, Shirvan A. 2001. Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? Cell Mol Neurobiol 21:215-235.
3. Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J. 1998. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92:1406-1414.
4. Ben-Shachar D, Zuk R, Glinka Y. 1995. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J Neurochem 64:718-723.
5. Berman SB, Hastings TG. 1999. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 73:1127-1137.
6. Betarbet R, Sherer TB, McKenzie G, García-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306.
7. Betarbet R, Sherer TB, Di Monte DA, Greenamyre JT. 2002. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol 12:499-510.
8. Fahn S. 1997. Levodopa-induced neurotoxicity. Does it represent a problem for the treatment of Parkinson's disease? CNS Drugs 8:376-393.
9. +-induced apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 55:620-628.
10. Fillox F, Townsend JJ. 1993. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119:79-88.
11. Furuya N, Kanazawa T, Fujimura S, Ueno T, Kominami E, Kadowaki M. 2001. Leupeptin-induced appearance of partial fragment of betaine homocysteine methyltransferase during autophagic maturation in rat hepatocytes. J Biochem 129:313-320.
12. Gómez C, Reiriz J, Piqué M, Gil J, Ferrer I, Ambrosio S. 2001. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 63:421-428.
13. + increases α-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res 935:32-39.
14. Graeber MB, Moran LB. 2002. Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 12:385-390.
15. Hammond CL, Lee TK, Ballatori N. 2001. Novel roles for glutathione in gene expression, cell death and membrane transport of organic solutes. J Hepatol 34:946-954.
16. Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E. 2002. α-Synuclein protects against c-jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 277:11465-11472.
17. Hoyt KR, Reynolds IJ, Hastings TG. 1997. Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp Neurol 143:269-281.
18. Iwata A, Maruyama M, Kanazawa I, Nukina N. 2001. α-Synuclein affects the MAPK pathway and accelerates cell death. J Biol Chem 276:45320-45329.
19. Junn E, Mouradian MM. 2001. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 78:374-383.
20. Junn E, Mouradian MM. 2002. Human α-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci Lett 320:146-150.
21. Kang CD, Jang JH, Kim KW, Lee HJ, Jeong CS, Kim CM, Kim SH, Chung BS. 1998. Activation of c-jun N-terminal kinase/stress-activated protein kinase and the decreased ratio of bcl-2 to bax are associated with the auto-oxidized dopamine-induced apoptosis in PC12 cells. Neurosci Lett 256:37-40.
22. Lai C-T, Yu PH. 1997. Dopamine- and 1-β-3,4-dihydroxyphenylalanine hydrochloride (I-dopa)-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells. Biochem Pharmacol 53:363-372.
23. Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D. 2002. Metamphetamine-induced degeneration of dopaminergic neurons involves autophagy and up-regulation of dopamine synthesis. J Neurosci 22:8951-8960.
24. Lee MH, Hyun D-H, Halliwell B, Jenner P. 2001. Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult. J Neurochem 76:998-1009.
25. Lode HD, Bruchelt G, Seitz J, Gebhart S, Gekelet V, Niethammer D, Beck J. 1995. Reverse transcriptase-polymerase chain reaction (RT-PCP,) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. Eur J Cancer 31:586-590.
26. Lotharius J, O'Malley KL. 2000. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. J Biol Chem 275:38581-38588.
27. Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P. 2002. Effect of mutant α-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277:38884-38894.
28. Luo Y, Kokkonen GC, Hattori A, Chrest FJ, Roth GS. 1999. Dopamine stimulates redox-tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells. Brain Res 850:21-38.
29. Maruyama W, Sango K, Iwasa K, Minami C, Dostert P, Kawai M, Moriyasu M, Naoi M. 2000. Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3′,4′-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines. Neurosci Lett 291:89-92.
30. Masserano JM, Gong L, Kulaga H, Baker I, Wyatt RJ. 1996. Dopamine induces apoptotic cell death of catecholaminergic cell line derived from the central nervous system. Mol Pharmacol 50:1309-1315.
31. McLaughlin BA, Nelson D, Erecinska M, Chesselet MF. 1998. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem 70:2406-2415.
32. Mena MA, de Yébenes J, Dwork A, Fahn S, Latov N, Herbert J, Flaster E, Slonin D. 1989. Biochemical properties of monoamine-rich human neuroblastoma cells. Brain Res 486:286-296.
33. Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC, Lau YS. 2002. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 956:156-165.
34. Michel PP, Hefti F. 1990. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurosis in culture. J Neurosci Res 25:428-435.
35. Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, Klionsky G, Ohsumi M. 1998. A protein conjugation system essential for autophagy. Nature 395:395-398.
36. Morikawa N, Nakagawa-Hattori Y, Mizuno Y. 1996. Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity. J Neurochem 66:1174-1181.
37. Offen D, Ziv I, Panet H, Wasserman L, Stein R, Melamed E, Barzilai A. 1997. Dopamine-induced apoptosis is inhibited in PC12 cells expressing bcl-2. Cell Mol Neurobiol 17:289-304.
38. Ohsumi Y. 2001. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev 2:211-216.
39. Petersen A, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P, Sulzer D. 2001. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet 10:1243-1254.
40. Pileblad E, Slivka A, Bratvold D, Cohen G. 1988. Studies on the autoxidation of dopamine: interaction with ascorbate. Arch Biochem Biophys 263:447-452.
41. Porat S, Premkumar A, Simantov R. 2001. Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53. Dev Neurosci 23:432-440.
42. Richards ML, Sadee W. 1986. Human neuroblastoma cell lines as models of catechol uptake. Brain Res 384:132-137.
43. Seglen PO, Gordon PB. 1982. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 79:1889-1892.
44. + induced apoptotic cell death in SH-SY5Y neuroblastoma cells: an electron microscope study. J Neurosci Res 48:226-237.
45. Simantov R, Blinder E, Ratovitski T, Tauber M, Gabbay M, Porat S. 1996. Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transported. Neuroscience 74:39-50.
46. Sookhai S, Wang JH, McCourt M, O'Donnel D, Redmond HP. 1999. Dopamine induces neutrophil apoptosis through a dopamine D-1 receptor-independent mechanism. Surgery 126:314-322.
47. Stefanis L, Larsen K, Rideout HJ, Sulzer D, Greene LA. 2001. Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21:9549-9560.
48. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446.
49. Vila M, Vukosavic S, Jackson LV, Neystat M, Jakowec M, Przedborski S. 2000. α-Synuclein up-regulation in substantia nigra of dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74:721-729.
50. Whitehead RE, Ferrer JV, Javitch JA, Justice JB. 2001. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transported. J Neurochem 76:1242-1251.
51. Wojcik C, Schroeter D, Wilk S, Lamprecht J, Paweletz N. 1996. Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur J Cell Biol 71:311-318.
52. Xu Y, Stokes AH, Roskoski R Jr, Vrana KE. 1998. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hyroxylase. J Neurosci Res 54:691-697.
53. Xue L, Fletcher GC, Tolkovsky AM. 1999. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 14:180-198.
54. Zhang J, Price JO, Graham DG, Montine TJ. 1998. Secondary excitotoxicity contribute to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochem Biophys Res Commun 248:812-816.
55. Zhou W, Schaack J, Zawada WM, Freed CR. 2002. Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res 926:42-50.
56. Zilkha-Falb R, Ziv I, Nardi N, Offen D, Melamed E, Barzilai A. 1997. Monoamine-induced apoptotic neuronal cell death. Cell Mol Neurobiol 17:101-118.
57. Ziv I, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A. 1994. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - a possible novel pathogenic mechanism in Parkinson's disease. Neurosci Lett 170:136-140.